Alain J. Cohen has served as a member of our Board of Directors since 2015. Since 2013, he has been the Co-Chief Executive Officer of Cobro Ventures, an investment management company for technology and biotechnology companies. Since December 2011, Alain has also been co-Chief Executive Officer of Bublup, Inc., an online knowledge-sharing and organization platform. Alain serves on the board of directors of Mana Therapeutics, Inc., a cellular therapies biotechnology company focused on educating immune cells to target cancer, as well as NextRNA, Inc., a biotechnology company focused on developing the next generation of RNA-directed therapeutics. In 1986, he co-founded and served as President and Chief Technology Officer of OPNET Technologies, Inc., a software company that provided performance management tools for computer networks and applications, through its acquisition in 2012. Alain holds a B.S. in Electrical Engineering from the Massachusetts Institute of Technology.